ArticleScientific reports2026
Comparative outcomes of osteoporotic fracture management between tertiary hospitals and fracture liaison services in Malaysia.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Osteoporotic fractures pose a significant health challenge, particularly among the elderly, resulting in diminished quality of life, increased morbidity and mortality, and substantial healthcare costs. In Malaysia, the incidence of osteoporotic fractures is expected to increase due to the country’s ageing population. This study evaluates the outcomes of osteoporotic fracture management in standard tertiary care (STC) hospitals compared to those in a Fracture Liaison Service (FLS)- accredited hospital. A retrospective cohort study was conducted in three STC hospitals and one FLS-accredited hospital. Medical records of patients aged 50 and above with osteoporotic fractures admitted to orthopaedic wards in 2021 were analysed. Data on demographics, clinical characteristics, and secondary fracture prevention measures were collected and compared. Statistical analysis was performed using IBM-SPSS software. At discharge, 66.0% of FLS patients were prescribed anti-osteoporosis medications compared to just 4.2% in STC hospitals (p < 0.001), with this trend continuing at six months (66.0% vs. 12.5%, p < 0.001). Supplement use was also higher among FLS patients (79.6% vs. 17.6%, p < 0.001), as was the rate of bone mineral density testing (40.8% vs. 2.3%, p < 0.001). In terms of recovery, FLS patients showed better post-fracture mobility (83.7% vs. 58.8%, p = 0.037) and greater independence at discharge (53.7% vs. 18.1%, p < 0.001). The study highlights a significant disparity between the two care models, particularly in secondary fracture prevention practices. These findings underscore the necessity for widespread implementation of structured fracture care programs to enhance patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.